Synapse - Matthew Matasar

Search Within

Matthew J Matasar

Results (293)

Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma

Meeting Abstract

Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
Blood (2015)

Fulltext@MSK | Save

A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning

Meeting Abstract

Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
Blood (2015)

Fulltext@MSK | Save

A prospective study of allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Perales, M. A.; Cho, C.; Eaton, A.; Moskowitz, A. J.; Nguyen, V.; Gonzales-Dadiz, A. M. R.; Devlin, S.; Giralt, S. A.; Jakubowski, A. A.; Matasar, M. J.; more...
Blood (2015)

Fulltext@MSK | Save

Differences in patients with progressive versus non-progressive AML, CLL, or NHL: Implications for proposed bundled payment strategies

Meeting Abstract

Byfield, S. D.; Engel-Nitz, N.; Bancroft, T.; Anderson, A. J.; Reyes, C.; Ravelo, A.; Ogale, S.; Chen, M.; Matasar, M. J.
Blood (2015)

Fulltext@MSK | Save

Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay

Meeting Abstract

Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
Blood (2015)

Fulltext@MSK | Save

Outcomes of pharmacokinetically (PK) directed busulfan in combination with thiotepa & cyclophosphamide (TBC) conditioning with HDT-ASCT in patients with primary & secondary CNS lymphoma

Meeting Abstract

Bhatt, V.; Scordo, M.; Hsu, M.; Omuro, A. M.; DeAngelis, L.; Lin, A.; Matasar, M. J.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; more...
Blood (2015)

Fulltext@MSK | Save

Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

Meeting Abstract

Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
Blood (2015)

Fulltext@MSK | Save

Toxicity of maintenance rituximab in older adults with non-Hodgkin lymphoma

Meeting Abstract

Matasar, M. J.; Atoria, C. L.; Elkin, E. B.; Nabhan, C.
Blood (2015)

Fulltext@MSK | Save

Survivorship care planning after participation in communication skills training intervention for a consultation about lymphoma survivorship

Journal Article

Banerjee, S. C.; Matasar, M. J.; Bylund, C. L.; Horwitz, S.; Mc Larney, K.; Levin, T.; Jacobsen, P. B.; Parker, P.; Astrow, A.; Kissane, D. W.
Translational Behavioral Medicine (2015)

Fulltext@MSK | Save

Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)

Meeting Abstract

Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save